Source: Beacon Pharmaceuticals PLC (BEACONPHAR) | FY 2018-19 | Page 79

# BEACON PHARMACEUTICALS LIMITED
## Statement of Profit & Loss and Other Comprehensive Income
### For the year ended 30 June 2019

Amount in Taka

| Particulars | Notes | 30 June 2019 | 30 June 2018 |
|---|---|---|---|
| Net Turnover | 29.00 | 4,646,865,410 | 3,760,786,106 |
| Less: Cost of Goods Sold | 30.00 | 2,364,808,809 | 1,927,331,673 |
| **Gross Profit** | | **2,282,056,601** | **1,833,454,433** |
| **Less: Operating Expenses:** | | | |
| Administrative Expenses | 31.00 | 286,081,646 | 239,590,025 |
| Marketing, Selling & Distribution Expenses | 32.00 | 1,673,366,718 | 1,324,256,067 |
| **Total Operating Expenses** | | **1,959,448,364** | **1,563,846,092** |
| **Operating Profit** | | **322,608,236** | **269,608,341** |
| Less: Financial Expenses | 33.00 | 153,524,466 | 138,082,326 |
| **Net Profit after Financial Expenses** | | **169,083,770** | **131,526,015** |
| Income from Other Sources | 34.00 | 2,487,251 | 811,526 |
| **Net Profit before contribution to WPPF** | | **171,571,021** | **132,337,541** |
| Less: Contribution to WPPF | 35.00 | 8,170,049 | 6,301,788 |
| **Net Profit before Tax** | | **163,400,973** | **126,035,753** |
| Less: Provision for Income Tax | | 40,850,243 | 31,508,938 |
| Add: Deferred Tax Income/(Expense) | | (4,850,138) | 31,576,193 |
| **Net profit after tax for the year** | | **117,700,592** | **126,103,008** |
| Other Comprehensive Income | | - | - |
| **Net profit after tax for the year** | | **117,700,592** | **126,103,008** |
| **Item that may be reclassified to profit or loss:** | | | |
| Unrealized Profit (loss) on quoted shares | 36.00 | (661,510) | (1,159,389) |
| **Total comprehensive income for the year** | | **117,039,082** | **124,943,619** |
| | | | |
| No. of Shares | | 231,000,000 | 231,000,000 |
| Earning Per Share | | 0.51 | 0.55 |